Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Gross Margin (2016 - 2025)

OptimizeRx's Gross Margin history spans 13 years, with the latest figure at 67.2% for Q3 2025.

  • For Q3 2025, Gross Margin rose 409.0% year-over-year to 67.2%; the TTM value through Sep 2025 reached 65.31%, up 272.0%, while the annual FY2024 figure was 64.45%, 447.0% up from the prior year.
  • Gross Margin for Q3 2025 was 67.2% at OptimizeRx, up from 63.83% in the prior quarter.
  • Across five years, Gross Margin topped out at 68.15% in Q4 2024 and bottomed at 54.54% in Q1 2021.
  • The 5-year median for Gross Margin is 61.98% (2024), against an average of 61.26%.
  • The largest annual shift saw Gross Margin soared 863bps in 2021 before it crashed -768bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 61.0% in 2021, then grew by 4bps to 63.37% in 2022, then dropped by -1bps to 62.89% in 2023, then grew by 8bps to 68.15% in 2024, then dropped by -1bps to 67.2% in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Gross Margin are 67.2% (Q3 2025), 63.83% (Q2 2025), and 60.85% (Q1 2025).